BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
113 hedge funds and large institutions have $254M invested in BioSpecifics Technologies Corp. in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 39 increasing their positions, 42 reducing their positions, and 13 closing their positions.
7% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 42
3% less funds holding
Funds holding: 116 → 113 (-3)
14% less capital invested
Capital invested by funds: $294M → $254M (-$40.3M)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSV Asset Management
Chicago,
Illinois
|
+$3.67M |
| 2 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$3.5M |
| 3 |
CIM
Contrarius Investment Management
St. Helier,
Jersey
|
+$2.12M |
| 4 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
+$1.68M |
| 5 |
MCM
Matarin Capital Management
New York
|
+$1.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$5.97M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.55M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.33M |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$1.66M |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
-$1.27M |
BSTC Hedge Fund Activity: Q3 2020 in Review
113 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2020, worth a combined $254M — down 14% from $294M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of BSTC and 10 opened new positions — a net loss of 3 holders — while 42 trimmed existing stakes and 39 added.
The largest buyer was LSV Asset Management, adding an estimated $3.67M. The largest seller was Russell Investments Group, cutting an estimated $5.97M.
- 113 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2020, down from 116 in Q2 2020.
- Funds reported $254M of BioSpecifics Technologies Corp. stock for Q3 2020, down 14% quarter-over-quarter.
- 10 funds opened new BioSpecifics Technologies Corp. positions in Q3 2020 and 13 closed out, a net change of -3 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q3 2020 was LSV Asset Management, an estimated $3.67M added.
- The largest BioSpecifics Technologies Corp. seller in Q3 2020 was Russell Investments Group, an estimated $5.97M sold.
Based on aggregated 13F filings for Q3 2020.